imiquimod has been researched along with aminolevulinic acid in 65 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (16.92) | 29.6817 |
| 2010's | 40 (61.54) | 24.3611 |
| 2020's | 14 (21.54) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bonnekoh, B; Cerburkovas, O; Gollnick, H; Krause, M; Ulrich, J | 1 |
| Alam, M; Goldberg, LH; Silapunt, S | 1 |
| Jorizzo, JL | 1 |
| Brownell, I | 1 |
| Gold, MH | 1 |
| Lear, JT; Madan, V; Murphy, JV; West, CA | 1 |
| Calvieri, S; Curzio, M; Devirgiliis, V; Gobbi, S; Panasiti, V; Roberti, V; Rossi, M | 1 |
| Downs, A; Muston, D; Rives, V | 1 |
| Apalla, Z; Ioannides, D; Maliamani, F; Panagiotidou, D; Sotiriou, E; Zaparas, N | 1 |
| Aguilar, M; Benítez, N; de Troya, M; González, M; Martin, L | 1 |
| Chimenti, S; Colombo, GL; Di Matteo, S; Fargnoli, MC; Frascione, P; Peris, K; Silipo, V | 1 |
| Wilson, EC | 1 |
| Goldenberg, G; Skupsky, H; Skupsky, J | 1 |
| Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C | 1 |
| Fernández Tirado, FJ; García Martín, E | 1 |
| Kouba, DJ; LoPiccolo, MC; Sage, RJ | 1 |
| Apalla, Z; Chovarda, E; Goussi, C; Ioannides, D; Lallas, A; Sotiriou, E; Trigoni, A | 1 |
| Botella-Estrada, R; Guillén, C; Hueso, L; Llombart, B; Messeguer, F; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V | 1 |
| Cotter, M; Florell, S; Hadley, J; Hadley, M; Hull, C; Tristani-Firouzi, P | 1 |
| Guillén, C; Llombart, B; Messeguer, F; Requena, C; Serra-Guillén, C | 1 |
| Gupta, AK; Paquet, M | 1 |
| Dummer, R | 1 |
| Arits, AH; De Rooij, MJ; Essers, BA; Kelleners-Smeets, NW; Krekels, GA; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJ; Rijzewijk, JJ; Sommer, A; Spoorenberg, E; Steijlen, PM; van Geest, AJ; van Neer, PA; van Pelt, HP | 1 |
| Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D | 1 |
| Aljuffali, IA; Fang, JY; Lee, WR; Li, YC; Shen, SC | 1 |
| Apalla, Z; Argenziano, G; Evangelou, G; Ioannides, D; Kyrgidis, A; Lallas, A; Lazaridou, E; Lefaki, I; Patsatsi, A; Sidiropoulos, T; Sotiriou, E; Stratigos, A; Trakatelli, M; Tzellos, T; Zalaudek, I | 1 |
| Jiayuan, C; Jing, W; Juan, X; Li, X; Qin, H; Qing, L; Shengmei, X | 1 |
| Arits, AH; Essers, BA; Kelleners-Smeets, NW; Mosterd, K; Nelemans, P; Spoorenberg, E | 1 |
| Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; Steijlen, PM | 1 |
| Bontumasi, NM; Hurst, EA; Sheinbein, D | 1 |
| Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Kleef, L; van Marion, AM; Winnepenninckx, VJ | 1 |
| Egekvist, H; Erlendsson, AM; Haedersdal, M; Lorentzen, HF; Philipsen, PA; Stausbøl-Grøn, B; Stender, IM | 1 |
| Alkemade, HA; Gerritsen, MJ; Groenewoud, H; Grutters, JP; Maessen-Visch, MB; Seubring, I; van de Kerkhof, PC; van der Wilt, GJ; van Doorn, R; van Rijsingen, MC | 1 |
| Chen, CC; Fang, JY; Kao, HC; Lin, YK; Yang, SH | 1 |
| Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
| Fabi, SG; Zaleski-Larsen, LA | 1 |
| Aljuffali, IA; Fang, JY; Huang, CW; Lee, WR; Lin, YK; Shen, SC | 1 |
| Arits, AH; Essers, BAB; Hendriks, MR; Kelleners-Smeets, NW; Mosterd, K | 1 |
| Gonzalez, H; Haedersdal, M; Halldin, C; Sandberg, C; Sørensen, SS; Togsverd-Bo, K; Wennberg, AM; Wulf, HC | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM; van Pelt, HPA | 1 |
| Shaw, FM; Weinstock, MA | 1 |
| Bauman, TM; Rosman, IS; Sheinbein, DM | 1 |
| Aberbigbe, O; Etzkorn, JR; Neal, DE; Smith, RJ | 1 |
| Bhatta, AK; Ji, J; Keyal, U; Wang, P; Wang, X; Zhang, G; Zhao, Z; Zhu, L | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Arits, AHMM; Hamid, MA; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Kouloubis, N; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Steijlen, PM; van Pelt, HPA | 1 |
| Chen, X; Fang, F; Yi, F; Zhang, J; Zheng, X; Zhou, B | 1 |
| Borik, L; Brunner, PM; Geusau, A; Mildner, M; Müllegger, R; Petzelbauer, P; Tzaneva, S | 1 |
| Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K | 1 |
| Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Merks, I; Mosterd, K; Nelemans, PJ | 1 |
| Kulakov, EL; Logan, IT; Perrett, CM | 1 |
| Berking, C; Heppt, MV; Steeb, T | 1 |
| Ali, FR; Raza, SA | 1 |
| Bath-Hextall, FJ; Hogan, S; Leonardi-Bee, J; Thomson, J; Williams, HC | 1 |
| Feldman, SR; Heron, CE | 1 |
| Ahmady, S; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ | 1 |
| Castagnetti, E; Cortelazzi, C; Di Nuzzo, S; Odorici, G; Pellacani, G | 1 |
| Cheng, B; Etzkorn, JR; Giordano, CN; Higgins, HW; Miller, CJ; Shin, TM; Sobanko, JF; Veerabagu, S | 1 |
| Chen, YC; Liu, WT; Lo, TK; Wong, TW | 1 |
| Arcuri, D; Iannattone, L; Lagacé, F; Lefrançois, P; Litvinov, IV; Netchiporouk, E; Ramchatesingh, B | 1 |
| Bargman, H; Sachdeva, M; Tai, F | 1 |
10 review(s) available for imiquimod and aminolevulinic acid
| Article | Year |
|---|---|
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A | 2003 |
Current and novel treatment options for actinic keratosis.
Topics: Aminolevulinic Acid; Aminoquinolines; Cryotherapy; Diclofenac; Fluorouracil; Gels; Humans; Imiquimod; Immunosuppressive Agents; Keratosis; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2004 |
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Retinoids; Vitamins | 2012 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Interventions for cutaneous Bowen's disease.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2013 |
Laser-Assisted Drug Delivery.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aminolevulinic Acid; Aminoquinolines; Analgesics; Antibodies; Antineoplastic Agents; Ascorbic Acid; Cyclopropanes; Dermatologic Agents; Drug Delivery Systems; Fluorouracil; Humans; Imiquimod; Immunotherapy; Laser Therapy; Methotrexate; Minoxidil; Permeability; Photosensitizing Agents; Polyesters; RNA, Small Interfering; Skin; Timolol; Vaccines | 2016 |
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome | 2020 |
Interventions for basal cell carcinoma of the skin.
Topics: Adult; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Female; Humans; Imiquimod; Immunocompetence; Laser Therapy; Male; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Radiotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome | 2020 |
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
Topics: Aminolevulinic Acid; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2023 |
Treatment Outcomes of Adjunct and Stand-alone Photodynamic Therapy in Patients With Extramammary Paget Disease: A Literature Review.
Topics: Aminolevulinic Acid; Humans; Imiquimod; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2023 |
14 trial(s) available for imiquimod and aminolevulinic acid
| Article | Year |
|---|---|
Intraindividual, right-left comparison of topical 5-aminolevulinic acid photodynamic therapy vs. 5% imiquimod cream for actinic keratoses on the upper extremities.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Interferon Inducers; Keratosis, Actinic; Male; Middle Aged; Ointments; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; Upper Extremity | 2009 |
A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminolevulinic Acid; Aminoquinolines; Child; Child, Preschool; Facial Dermatoses; Female; Humans; Imiquimod; Infant; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Young Adult | 2011 |
A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Female; Humans; Imiquimod; Immunocompetence; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Treatment Outcome | 2012 |
Results of an investigator-initiated single-blind split-face comparison of photodynamic therapy and 5% imiquimod cream for the treatment of actinic keratoses.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Facial Dermatoses; Humans; Imiquimod; Interferon Inducers; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Quality of Life; Single-Blind Method; Treatment Outcome | 2012 |
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prognosis; Single-Blind Method; Skin Neoplasms | 2013 |
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cost Savings; Cost-Benefit Analysis; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2014 |
Photodynamic therapy vs. topical imiquimod for treatment of superficial basal cell carcinoma: a subgroup analysis within a noninferiority randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Single-Blind Method; Skin Neoplasms; Treatment Outcome | 2015 |
Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Choice Behavior; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2018 |
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2018 |
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Imiquimod; Intention to Treat Analysis; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Scalp Dermatoses; Single-Blind Method; Skin Cream; Treatment Outcome | 2019 |
Peptidase inhibitor 3 and chemokine ligand 27 may serve as biomarkers for actinic keratoses in organ transplant recipients.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Biomarkers; Chemokine CCL27; Elafin; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Prospective Studies; Reference Values; RNA, Messenger; Severity of Illness Index; Transplant Recipients; Treatment Outcome | 2019 |
A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherla
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2020 |
The Effect of Four Approaches to Treat Actinic Keratosis on the Health-Related QOL, as Assessed by the Skindex-29 and Actinic Keratosis QOL.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Photochemotherapy; Quality of Life; Skin Cream; Surveys and Questionnaires; Treatment Outcome | 2021 |
Comparative study of imiquimod 3.75% vs. photodynamic therapy for actinic keratosis of the scalp.
Topics: Aminolevulinic Acid; Humans; Imiquimod; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Scalp; Treatment Outcome | 2021 |
41 other study(ies) available for imiquimod and aminolevulinic acid
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Disseminated actinic keratoses. Comparison of topical photodynamic therapy with 5-aminolevulinic acid and topical 5% imiquimod cream].
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Female; Follow-Up Studies; Humans; Imiquimod; Keratitis; Ointments; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Time Factors | 2001 |
New treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cryosurgery; Diclofenac; Gels; Imiquimod; Ointments; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents | 2002 |
New treatments for actinic keratoses.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Dermatologic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Sunscreening Agents; United States | 2002 |
Nodular basal cell carcinoma: when in doubt, cut it out.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Humans; Imiquimod; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure | 2007 |
Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
Topics: Aminolevulinic Acid; Aminoquinolines; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cryotherapy; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Treatment Outcome | 2008 |
Sequential treatment of giant basal cell carcinomas.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2009 |
Complete remission of nodular basal cell carcinoma after combined treatment with photodynamic therapy and imiquimod 5% cream.
Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Ointments; Photochemotherapy; Photosensitizing Agents; Remission Induction; Skin Neoplasms | 2008 |
An economic evaluation of topical treatments for actinic keratosis.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; United Kingdom | 2009 |
A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen's disease of the lower extremities.
Topics: Aminolevulinic Acid; Aminoquinolines; Bowen's Disease; Carcinoma, Basal Cell; Cost-Benefit Analysis; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms | 2010 |
Cost-effectiveness analysis of topical treatments for actinic keratosis in the perspective of the Italian health care system.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Decision Trees; Delivery of Health Care; Diclofenac; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic | 2010 |
Cost effectiveness of imiquimod 5% cream compared with methyl aminolevulinate-based photodynamic therapy in the treatment of non-hyperkeratotic, non-hypertrophic actinic (solar) keratoses: a decision tree model.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Data Interpretation, Statistical; Decision Trees; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Quality-Adjusted Life Years; United Kingdom | 2010 |
[Periocular basal cell carcinoma treatment tendencies].
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Conjunctival Neoplasms; Eyelid Neoplasms; Humans; Imiquimod; Immunologic Factors; Mohs Surgery; Neoplasms, Radiation-Induced; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Sunlight | 2010 |
Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Adenoid Cystic; Carcinoma, Skin Appendage; Combined Modality Therapy; Humans; Imiquimod; Lasers, Solid-State; Male; Middle Aged; Neoplastic Syndromes, Hereditary; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2011 |
Sequential use of photodynamic therapy and imiquimod 5% cream for the treatment of actinic cheilitis: a 12-month follow-up study.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Aminoquinolines; Cheilitis; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2011 |
Facial extensive recurrent basal cell carcinoma: successful treatment with photodynamic therapy and imiquimod 5% cream.
Topics: Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2012 |
Treating basal-cell carcinoma in a real life setting.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2013 |
Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Animals; Drug Delivery Systems; Female; Hydrophobic and Hydrophilic Interactions; Imiquimod; Lasers; Mice; Mice, Inbred ICR; Mice, Nude; Nanoparticles; Permeability; Pharmaceutical Vehicles; Polyethylene Glycols; Propylene Glycol; Skin; Skin Absorption; Water | 2014 |
Applicability of dermoscopy for evaluation of patients' response to nonablative therapies for the treatment of superficial basal cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Dermoscopy; Humans; Imiquimod; Male; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2014 |
Complete remission of two patients with recurrent and wide spread extramammary Paget disease obtained from 5-aminolevulinic acid-based photodynamic therapy and imiquimod combination treatment.
Topics: Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Drug Therapy, Combination; Genital Neoplasms, Male; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photosensitizing Agents; Remission Induction; Skin Neoplasms; Treatment Outcome | 2014 |
Combination therapy for perianal squamous cell carcinoma in situ with imiquimod and photodynamic therapy.
Topics: Aminolevulinic Acid; Aminoquinolines; Anal Canal; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Dissection; Female; Humans; Imiquimod; Middle Aged; Neoplasm, Residual; Photochemotherapy; Photosensitizing Agents; Postoperative Complications; Skin Neoplasms; Treatment Outcome | 2014 |
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden | 2015 |
Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cross-Sectional Studies; Cryotherapy; Denmark; Dermatology; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Outpatient Clinics, Hospital; Photochemotherapy; Photosensitizing Agents; Practice Patterns, Physicians'; Private Practice; Sex Factors; Skin Neoplasms | 2016 |
Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Dermatologic Agents; Drug Costs; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Netherlands; Patient Preference; Photochemotherapy; Photosensitizing Agents; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Using Imiquimod-Induced Psoriasis-Like Skin as a Model to Measure the Skin Penetration of Anti-Psoriatic Drugs.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Cytokines; Disease Models, Animal; Female; Imiquimod; Mice; Psoriasis; Skin; Skin Absorption; Tacrolimus; Tretinoin | 2015 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Non-ablative fractional laser assists cutaneous delivery of small- and macro-molecules with minimal bacterial infection risk.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Animals; Dextrans; Drug Delivery Systems; Fluorescein; Fluorescein-5-isothiocyanate; Imiquimod; Lasers, Solid-State; Mice, Inbred BALB C; Mice, Nude; Peptides; Pseudomonas aeruginosa; Pseudomonas Infections; Quantum Dots; Skin; Skin Absorption; Staphylococcal Infections; Staphylococcus aureus; Swine; Tretinoin | 2016 |
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Skin Neoplasms | 2018 |
Comparing Topical Treatments for Basal Cell Carcinoma.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2018 |
Extramammary Paget's disease of the scrotum with complete response to imiquimod and photodynamic therapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Biopsy; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Scrotum | 2018 |
Cells to Surgery Quiz: July 2018.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Eruptions; Equivalence Trials as Topic; Face; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome | 2018 |
Therapeutic effect of Imiquimod enhanced ALA-PDT on cutaneous squamous cell carcinoma.
Topics: Aged; Aminolevulinic Acid; Animals; Apoptosis; Carcinoma, Squamous Cell; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Imiquimod; Inflammation Mediators; Male; Mice; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; T-Lymphocytes | 2018 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Equivalence Trials as Topic; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure | 2019 |
ALA-PDT alleviates the psoriasis by inhibiting JAK signalling pathway.
Topics: Aminolevulinic Acid; Animals; Drug Evaluation, Preclinical; Female; Imiquimod; Interferon-gamma; Janus Kinases; Keratinocytes; Mice, Inbred BALB C; Photochemotherapy; Photosensitizing Agents; Psoriasis; Reactive Oxygen Species; Signal Transduction; Suppressor of Cytokine Signaling Proteins | 2019 |
Sequential Treatment of Superficial Basal Cell Carcinomas With Topical Methyl Aminolevulinate Photodynamic Therapy and Imiquimod 5% Cream: A Retrospective Study of Clinical and Cosmetic Outcomes.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Combined Modality Therapy; Esthetics; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Cream; Skin Neoplasms; Treatment Outcome | 2020 |
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy | 2020 |
Comparison of efficacy of field treatments for actinic keratoses.
Topics: Adult; Aminolevulinic Acid; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Scalp Dermatoses | 2020 |
Ingenol Mebutate and the Treatment of Actinic Keratosis.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2021 |
A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2022 |
Successful treatment of giant Bowen's disease with photodynamic therapy and subsequent imiquimod in a case with chronic arsenic exposure.
Topics: Aminolevulinic Acid; Bowen's Disease; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2022 |